Displaying all 5 Episode of Augmented Ops with the tag “pharma”.
-
The Future of Quality and Validation with AstraZeneca’s Bob Buhlmann
June 4th, 2025 | Season 5 | 28 mins 59 secs
pharma, quality, validation
Bob Buhlmann, Head of Quality Digital and Computer Strategy at AstraZeneca explores the evolution of quality in the pharma industry, the role of validation in an era of rapid technological advancement, and why pharma can be so slow to adopt new tech.
-
Lighthouses, Lean, and the Human Factor in Digital Transformation with AstraZeneca’s Jim Fox
May 7th, 2025 | Season 5 | 24 mins 49 secs
automation, change management, lean, pharma
Jim Fox, SVP Americas Supply Operations at AstraZeneca, shares his perspective on humans vs. automation in pharma manufacturing, building trust in emerging tech, and how agility and lean principles drive innovation in an increasingly personalized industry.
-
Rethinking Governance, eBR, and the CIO Role from the Ground Up with NextPharma’s Joel Fidalgo
April 23rd, 2025 | Season 5 | 29 mins 4 secs
ebr, governance, pharma, quality
Joel Fidalgo, CIO of Next Pharma, shares a CDMO’s perspective on how to bridge IT and operations, taking a new approach to MES and eBR, and the challenges of agility, quality, and data integration in the pharma space.
-
A New Approach to Pharma Manufacturing with Roche’s Daniele Iacovelli
October 9th, 2024 | Season 5 | 34 mins 18 secs
ai, architecture, citizen development, composability, mes, pharma, validation
Daniele Iacovelli, SVP, Global Head of Digital, Analytics (AI) & Operational Excellence at Roche discusses Roche’s digital transformation, his perspective on citizen development, and why the traditional software validation approach is no longer sufficient.
-
Episode 125: Rethinking Quality Control for Pharmaceuticals with Mark Buswell
November 1st, 2023 | Season 4 | 23 mins 14 secs
4ir, ai, automation, digital transformation, industry 4.0, manufacturing, pharma, pharmaceuticals, quality, quality control, software, technology
Mark Buswell, VP of Quality Tech at GSK brings over two decades of experience digitizing pharmaceutical manufacturing as we explore the challenges of quality control and his vision to enable a paradigm shift in the industry through 'Quality by Design.'